Peng-Fei Zhang - Search Results

Year	Number of Results
2002	1
2003	5
2004	2
2005	3
2006	8
2007	13
2008	11
2009	10
2010	15
2011	10
2012	8
2013	7
2014	12
2015	12
2016	16
2017	10
2018	13
2019	28
2020	26
2021	14
2022	23
2023	21
2024	8

1

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.

Wang SW, Gao C, Zheng YM, Yi L, Lu JC, Huang XY, Cai JB, Zhang PF, Cui YH, Ke AW. Wang SW, et al. Among authors: zhang pf. Mol Cancer. 2022 Feb 21;21(1):57. doi: 10.1186/s12943-022-01518-8. Mol Cancer. 2022. PMID: 35189910 Free PMC article. Review.

2

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma.

Wei CY, Zhu MX, Zhang PF, Huang XY, Wan JK, Yao XZ, Hu ZT, Chai XQ, Peng R, Yang X, Gao C, Gao J, Wang SW, Zheng YM, Tang Z, Gao Q, Zhou J, Fan JB, Ke AW, Fan J. Wei CY, et al. Among authors: zhang pf. J Hepatol. 2022 Jul;77(1):163-176. doi: 10.1016/j.jhep.2022.02.019. Epub 2022 Feb 24. J Hepatol. 2022. PMID: 35219791 Free article.

3

CXCL1-CXCR2 signalling mediates hypertensive retinopathy by inducing macrophage infiltration.

Wang S, Bai J, Zhang YL, Lin QY, Han X, Qu WK, Zhang PF, Ge YS, Zhao Q, Li HH. Wang S, et al. Among authors: zhang pf. Redox Biol. 2022 Oct;56:102438. doi: 10.1016/j.redox.2022.102438. Epub 2022 Aug 13. Redox Biol. 2022. PMID: 35981418 Free PMC article.

4

Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.

Lu JC, Zhang PF, Huang XY, Guo XJ, Gao C, Zeng HY, Zheng YM, Wang SW, Cai JB, Sun QM, Shi YH, Zhou J, Ke AW, Shi GM, Fan J. Lu JC, et al. Among authors: zhang pf. J Hematol Oncol. 2021 Nov 27;14(1):200. doi: 10.1186/s13045-021-01207-x. J Hematol Oncol. 2021. PMID: 34838121 Free PMC article.

5

Macro CD5L⁺ deteriorates CD8⁺T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.

Lu JC, Wu LL, Sun YN, Huang XY, Gao C, Guo XJ, Zeng HY, Qu XD, Chen Y, Wu D, Pei YZ, Meng XL, Zheng YM, Liang C, Zhang PF, Cai JB, Ding ZB, Yang GH, Ren N, Huang C, Wang XY, Gao Q, Sun QM, Shi YH, Qiu SJ, Ke AW, Shi GM, Zhou J, Sun YD, Fan J. Lu JC, et al. Among authors: zhang pf. Nat Commun. 2024 Jan 20;15(1):621. doi: 10.1038/s41467-024-44795-1. Nat Commun. 2024. PMID: 38245530 Free PMC article.

6

The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.

Zhang LX, Gao J, Long X, Zhang PF, Yang X, Zhu SQ, Pei X, Qiu BQ, Chen SW, Lu F, Lin K, Xu JJ, Wu YB. Zhang LX, et al. Among authors: zhang pf. Mol Cancer. 2022 May 7;21(1):110. doi: 10.1186/s12943-022-01586-w. Mol Cancer. 2022. PMID: 35525959 Free PMC article.

7

Ubiquitin-specific peptidase 1: assessing its role in cancer therapy.

Huang P, Wang Y, Zhang P, Li Q. Huang P, et al. Clin Exp Med. 2023 Nov;23(7):2953-2966. doi: 10.1007/s10238-023-01075-4. Epub 2023 Apr 24. Clin Exp Med. 2023. PMID: 37093451 Review.

8

Downregulation of RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma.

Wei CY, Zhu MX, Yang YW, Zhang PF, Yang X, Peng R, Gao C, Lu JC, Wang L, Deng XY, Lu NH, Qi FZ, Gu JY. Wei CY, et al. Among authors: zhang pf. J Hematol Oncol. 2019 Mar 4;12(1):21. doi: 10.1186/s13045-019-0711-z. J Hematol Oncol. 2019. PMID: 30832692 Free PMC article.

9

Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.

Zhang PF, Gao C, Huang XY, Lu JC, Guo XJ, Shi GM, Cai JB, Ke AW. Zhang PF, et al. Mol Cancer. 2020 Jun 27;19(1):110. doi: 10.1186/s12943-020-01222-5. Mol Cancer. 2020. PMID: 32593303 Free PMC article.

10

Causal relationship between cannabis use and cancer: a genetically informed perspective.

Huang P, Zhang PF, Li Q. Huang P, et al. Among authors: zhang pf. J Cancer Res Clin Oncol. 2023 Sep;149(11):8631-8638. doi: 10.1007/s00432-023-04807-x. Epub 2023 Apr 26. J Cancer Res Clin Oncol. 2023. PMID: 37099198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

243 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Results by year